Dr Peter Salgo | Health & Wellness
Dr Peter Salgo | Health & Wellness – www.crownspeakers.com For more information on Peter Salgo please contact Crown Speakers Bureau at 1.877.8-TALENT (1.877.882.5368) or visit ?www.crownspeakers.com Dr. Peter Salgo—an experienced medical correspondent, professor and practicing physician—is one of this country’s most respected health care futurists. In addition to having spoken before hundreds of professional and lay audiences, Dr. Salgo is known for his written work. In just the last two years, he has published articles on such timely issues as drug pricing schedules in the United States as compared to those of other Western nations; Chronic Fatigue Syndrome; the current progress of fetal surgery; Retin A—its risks and benefits; plastic and cosmetic surgery; and AIDS—its effects upon its victims and the health care system in general. Additionally, millions have viewed Dr. Salgo on television and have listened to him on the radio. His broadcast lectures were aired on the CBS Television Network and its affiliated Stations, the CBS Radio Network and its affiliated Stations, as well as the CNBC Television Network and its affiliated Stations. Most recently, he wrote, produced and anchored four broadcasts per week for CNBC’s America’s Vital Signs. For the past ten years, he has served as a correspondent with WCBS-TV News—writing, producing, edited, directing and commenting upon medical news and education issues. The most popular of his reports was entitled AIDS and the Homeless. Others included in-depth looks into …
Young professionals join fight against drugs
Filed under: drug treatment news stories
Young Professionals of East Kentucky members came to Chad's Hope rehabilitation center in Clay County to hear from people who have battled addiction and are turning their lives around. They said they came to hear the stories of former addicts, like …
Read more on WKYT
This Week in Biotech: Part 2
Filed under: drug treatment news stories
Here's the skinny on a few noteworthy stories that may have slipped under your radar with the elections occurring this week. Microcap Catalyst Pharmaceutical Partners (Nasdaq: CPRX ) more than lived up … Not only did the drug not prove more effective …
Read more on Motley Fool